当前位置: X-MOL 学术J. Diabetes › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Efficacy and safety of lixisenatide as add-on therapy to basal insulin in older adults with type 2 diabetes in the GetGoal-O Study.
Journal of Diabetes ( IF 3.0 ) Pub Date : 2019-06-26 , DOI: 10.1111/1753-0407.12952
George E Dailey 1 , Terry A Dex 2 , Michelle Roberts 2 , Minzhi Liu 2 , Graydon S Meneilly 3
Affiliation  

This study compared the efficacy and safety of lixisenatide with placebo as add‐on therapy to basal insulin (BI) in adults aged ≥70 years with type 2 diabetes (T2D), with or without moderate renal insufficiency.

中文翻译:

在GetGoal-O研究中,利西拉来作为基础2型糖尿病成年人基础胰岛素补充治疗的功效和安全性。

这项研究比较了利西拉肽和安慰剂作为基础胰岛素(BI)在70岁以上患有2型糖尿病(T2D)且有或没有中度肾功能不全的成年人中的基础治疗的有效性和安全性。
更新日期:2019-06-26
down
wechat
bug